Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 51–100 of 254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05857969	Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling	recruiting	Phase 1	65	Florida International UniversityOTHER	1	Aug 26, 2026	clinicaltrials
NCT07617727	A Phase I Study of JSKN021 in Advanced Solid Tumors	recruiting	Phase 1	199	Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY	1	Aug 26, 2026	clinicaltrials